• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚马菌素固定纤维柱降低特发性肺纤维化急性加重患者血清高迁移率族蛋白 B 水平。

Reduction in serum high mobility group box-1 level by polymyxin B-immobilized fiber column in patients with idiopathic pulmonary fibrosis with acute exacerbation.

机构信息

Department of Pulmonary Medicine/Infection and Oncology, Internal Medicine, Nippon Medical School, Tokyo, Japan. sabe @ nms.ac.jp

出版信息

Blood Purif. 2011;32(4):310-6. doi: 10.1159/000330325. Epub 2011 Sep 2.

DOI:10.1159/000330325
PMID:21893977
Abstract

BACKGROUND/AIM: Recent reports suggest that polymyxin B (PMX)-immobilized fiber may have beneficial effects in idiopathic pulmonary fibrosis (IPF) with acute exacerbation (AE). High mobility group box-1 (HMGB-1) is an important pro-inflammatory mediator that contributes to acute lung inflammation. This study was aimed to investigate whether PMX treatment affects serum HMGB-1 levels and oxygenation in IPF patients with AE.

MATERIALS AND METHODS

Twenty IPF patients with AE were treated by PMX. PMX treatment was carried out once daily for 2 successive days. Serum HMGB-1 levels were measured before and after PMX treatment. We also monitored arterial oxygen tension (PaO(2))/inspiratory oxygen fraction (FiO(2)) (P/F) ratio. PMX fiber columns were analyzed to examine whether HMGB-1 was absorbed by PMX.

RESULTS

PMX treatment significantly improved both the serum HMGB-1 level and P/F ratio. HMGB-1 was detected in washing medium from the PMX column.

CONCLUSION

PMX treatment may reduce serum HMGB-1 and improve oxygenation in patients with IPF with AE.

摘要

背景/目的:最近的报告表明,多黏菌素 B(PMX)固定纤维可能对特发性肺纤维化(IPF)伴急性加重(AE)具有有益作用。高迁移率族蛋白 B1(HMGB-1)是一种重要的促炎介质,有助于急性肺炎症。本研究旨在探讨 PMX 治疗是否影响 AE 型 IPF 患者的血清 HMGB-1 水平和氧合。

材料和方法

20 例 AE 型 IPF 患者接受 PMX 治疗。PMX 治疗连续进行 2 天,每天 1 次。在 PMX 治疗前后测量血清 HMGB-1 水平。我们还监测了动脉氧分压(PaO2)/吸入氧分数(FiO2)(P/F)比值。分析 PMX 纤维柱以检查 HMGB-1 是否被 PMX 吸收。

结果

PMX 治疗显著改善了血清 HMGB-1 水平和 P/F 比值。从 PMX 柱的洗涤液中检测到 HMGB-1。

结论

PMX 治疗可降低 AE 型 IPF 患者的血清 HMGB-1 水平并改善氧合。

相似文献

1
Reduction in serum high mobility group box-1 level by polymyxin B-immobilized fiber column in patients with idiopathic pulmonary fibrosis with acute exacerbation.聚马菌素固定纤维柱降低特发性肺纤维化急性加重患者血清高迁移率族蛋白 B 水平。
Blood Purif. 2011;32(4):310-6. doi: 10.1159/000330325. Epub 2011 Sep 2.
2
Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis.多黏菌素B固定化纤维柱(PMX)治疗特发性肺纤维化急性加重:一项多中心回顾性分析
Intern Med. 2012;51(12):1487-91. doi: 10.2169/internalmedicine.51.6965. Epub 2012 Jun 15.
3
Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival.使用多粘菌素B固定化纤维柱进行直接血液灌流治疗特发性肺纤维化急性加重可提高生存率。
BMC Pulm Med. 2015 Feb 22;15:15. doi: 10.1186/s12890-015-0004-4.
4
Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.多黏菌素B固定化纤维对脓毒症休克患者的疗效与高迁移率族蛋白B1的关系
ASAIO J. 2007 May-Jun;53(3):324-8. doi: 10.1097/MAT.0b013e3180340301.
5
Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: serum IL-7 as a prognostic marker.多粘菌素B血液灌流治疗特发性肺纤维化急性加重:血清白细胞介素-7作为预后标志物
Sarcoidosis Vasc Diffuse Lung Dis. 2011 Oct;28(2):113-22.
6
Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.多黏菌素B固定化纤维血液灌流对急性呼吸窘迫综合征患者血清高迁移率族蛋白B1水平及氧化应激的影响
ASAIO J. 2009 Jul-Aug;55(4):395-9. doi: 10.1097/MAT.0b013e3181a5290f.
7
Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis.特发性肺纤维化急性加重期接受或未接受多粘菌素B固定纤维柱直接血液灌流的生存情况:一项回顾性分析
Intern Med. 2016;55(24):3551-3559. doi: 10.2169/internalmedicine.55.6056. Epub 2016 Dec 15.
8
Cytokine Adsorption to Polymyxin B-Immobilized Fiber: An in vitro Study.细胞因子吸附至多粘菌素 B 固定化纤维:一项体外研究。
Blood Purif. 2021;50(2):230-237. doi: 10.1159/000510290. Epub 2020 Sep 7.
9
HMGB-1 as a useful prognostic biomarker in sepsis-induced organ failure in patients undergoing PMX-DHP.HMGB-1 作为 PMX-DHP 治疗脓毒症诱导的器官衰竭患者的有用预后生物标志物。
J Surg Res. 2011 Nov;171(1):183-90. doi: 10.1016/j.jss.2009.11.708. Epub 2009 Dec 10.
10
Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia.聚砜膜血液灌流联合多黏菌素 B 固定化纤维治疗间质性肺炎急性加重期
Respirology. 2017 Oct;22(7):1357-1362. doi: 10.1111/resp.13054. Epub 2017 Apr 25.

引用本文的文献

1
Polymyxin B-hemoperfusion in patients with acute exacerbation of idiopathic pulmonary fibrosis: a single-center prospective pilot study.多黏菌素B血液灌流治疗特发性肺纤维化急性加重期患者:一项单中心前瞻性初步研究。
Korean J Intern Med. 2025 May;40(3):458-467. doi: 10.3904/kjim.2024.244. Epub 2025 Apr 30.
2
Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 Patients.接受PMX-DHP治疗的COVID-19患者的炎症和凝血标志物变化
Cureus. 2025 Feb 10;17(2):e78836. doi: 10.7759/cureus.78836. eCollection 2025 Feb.
3
Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study.
多黏菌素B固定纤维柱治疗机械通气的特发性肺纤维化患者急性加重期:一项全国性观察性研究
J Intensive Care. 2023 Oct 11;11(1):45. doi: 10.1186/s40560-023-00693-0.
4
Pathological Roles of Pulmonary Cells in Acute Lung Injury: Lessons from Clinical Practice.急性肺损伤中肺细胞的病理作用:来自临床实践的教训。
Int J Mol Sci. 2022 Nov 30;23(23):15027. doi: 10.3390/ijms232315027.
5
Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study.使用多粘菌素B固定化聚苯乙烯柱对COVID-19患者进行直接血液灌流的有效性和安全性:一项探索性研究方案
JMIR Res Protoc. 2022 Nov 16;11(11):e37426. doi: 10.2196/37426.
6
Acute exacerbation of interstitial lung disease in the intensive care unit.重症监护病房中的间质性肺疾病急性加重
World J Crit Care Med. 2022 Jan 9;11(1):22-32. doi: 10.5492/wjccm.v11.i1.22.
7
Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients.循环 HMGB1 在肺癌患者术后间质性肺病急性加重中的预测作用。
Sci Rep. 2021 May 12;11(1):10105. doi: 10.1038/s41598-021-89663-w.
8
PMX-DHP Therapy for Dyspnea and Deoxygenation in Severe COVID-19 Pneumonia: A Case Series.PMX-DHP治疗重症新型冠状病毒肺炎的呼吸困难和低氧血症:病例系列
Infect Drug Resist. 2021 Apr 6;14:1305-1310. doi: 10.2147/IDR.S299023. eCollection 2021.
9
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.COVID-19 患者采用多粘菌素 B 固定化聚苯乙烯柱进行直接血液灌流。
J Clin Apher. 2021 Jun;36(3):313-321. doi: 10.1002/jca.21861. Epub 2020 Dec 15.
10
Acute exacerbation of idiopathic pulmonary fibrosis: who to treat, how to treat.特发性肺纤维化急性加重:治疗对象及治疗方法
Curr Pulmonol Rep. 2019 Dec;8(4):123-130. doi: 10.1007/s13665-019-00238-7. Epub 2019 Nov 26.